{"id":91210,"date":"2023-12-05T09:39:46","date_gmt":"2023-12-05T04:09:46","guid":{"rendered":"http:\/\/finservwealth.com\/us-fda-hits-intas-pharma-with-warning-letter-notes-data-integrity-lapses-at-ahmedabad-plant-2\/"},"modified":"2023-12-05T09:39:46","modified_gmt":"2023-12-05T04:09:46","slug":"us-fda-hits-intas-pharma-with-warning-letter-notes-data-integrity-lapses-at-ahmedabad-plant-2","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/us-fda-hits-intas-pharma-with-warning-letter-notes-data-integrity-lapses-at-ahmedabad-plant-2\/","title":{"rendered":"US FDA hits Intas Pharma with warning letter; notes data integrity lapses at Ahmedabad plant"},"content":{"rendered":"<p> The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits<\/p><div id=\"finse-341209926\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/us-fda-hits-intas-pharmawarning-letter-notes-data-integrity-lapses-at-ahmedabad-plant_17359721.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/us-fda-hits-intas-pharmawarning-letter-notes-data-integrity-lapses-at-ahmedabad-plant_17359721.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/us-fda-hits-intas-pharmawarning-letter-notes-data-integrity-lapses-at-ahmedabad-plant_17359721.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/us-fda-hits-intas-pharmawarning-letter-notes-data-integrity-lapses-at-ahmedabad-plant_17359721.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-91210","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2017\/200x200\/U\/USFDA-Warning-letter1_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/91210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=91210"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/91210\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=91210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=91210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=91210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}